Healthcare / Health Information ServicesNasdaqCM
$0.42
-0.01 (-2.28%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-5.9M · quality 50.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
24/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-135.8%
↓Gross Margin
54.9%
↑Debt/Equity
0.02
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+270.9%
FCF CAGR
—
FCF margin
-1282.9%
FCF / Net income
0.28x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $456021.0 · net income $-20.6M · FCF $-5.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $456021.00 | $456021.00 | $615873.00 | $731493.00 | $8939.00 |
| Net Income | $-20.6M | $-20.6M | $-8.7M | $-9.2M | $-2.0M |
| EBITDA | $-18.8M | $-18.8M | $-8.0M | $-9.1M | $-2.0M |
| EPS | -2.17 | -2.17 | -4.80 | -8.58 | -1.96 |
| Gross Margin | 54.9% | 54.9% | 61.7% | 59.0% | 54.3% |
| Operating Margin | -4200.5% | -4200.5% | -1411.6% | -1260.3% | -22279.7% |
| Net Margin | -4526.8% | -4526.8% | -1413.6% | -1259.4% | -22352.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.02 | 0.02 | 0.02 | 0.17 | 0.57 |
| Current Ratio | 0.29 | 0.29 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-5.9M | $-5.9M | $-4.9M | $-7.0M | $-1.4M |
| Returns | |||||
| ROE | -135.8% | -135.8% | -62.4% | -1189.1% | -325.4% |
| Valuation | |||||
| P/B | 0.28 | 0.28 | 0.35 | 5.41 | — |
| Growth & Yield | |||||
| Revenue Growth | -26.0% | -26.0% | -15.8% | 8083.2% | — |
| EPS Growth | 54.8% | 54.8% | 44.1% | -338.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-80.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-4.80 → -2.17
Residual
-80.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.